Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Hesperos" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Hesperos for you to read. Along with our medical data and news we also list Hesperos Clinical Trials, which are updated daily. BioPortfolio also has a large database of Hesperos Companies for you to search.
Hesperos is focused on characterizing an individual’s biology with human-on-a-chip microfluidic systems. The human-on-a-chip model will mimic the biology of AD and the effects of potential new therapies The post Hesperos secures NIH grant to create human-on-a-chip model to mimic Alzheimer’s disease appeared first on Compelo Medical Devices.
Orlando Company Awarded Phase I Small Business Innovation Research Grant from NIH to Fast-Track Project Hesperos, Inc., announced today the receipt of a NIH Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Institute on Aging (NIA) to help create a new multi-organ “human-on-a-chip” model t...
Human-on-a-chip Company Hesperos Licenses First Functional Stem-Cell Derived Neuromuscular Junction Model Innovative microfluidic device could transform drug testing for ALS and other neurodegenerative diseases
Hesperos, Inc. has announced that it has been named one of the 50 statewide companies expected to see significant growth over the next several years by GrowFL. The 50 companies were selected from more than 500 nominees for Florida Companies to WatchSM, a statewide program managed by economic development group GrowFL, in association with the Edward Lowe Fou...
- Hesperos is the first tissue chip company to receive Phase IIb grant - Hesperos, Inc., (www.hesperosinc.com) announced today the receipt of a $4 million three-year NIH Phase IIb Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to increase c...
Innovative microfluidic device could transform drug testing for ALS and other neurodegenerative diseases Hesperos, Inc. has increased its pioneering human-on-a-chip drug testing capabilities by adding a new in vitro, human-human neuromuscular model to its patented multi-organ microfluidic device systems. Abnormal function of the neuromuscular junction ...
Hesperos, Inc. has announced that it is among the first round of finalists for the 2018 Florida Companies to Watch honor, recently announced by GrowFL. The awards event - now in its eighth year - honors 50 select second-stage companies from throughout the state for developing valuable products and services, creating quality jobs, enriching communi...